目次

Table of Contents

Chapter 1. Research Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Test
1.1.2. End Use
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline.
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database.
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.2. Approach 1: Commodity flow approach
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Test outlook
2.2.2. End use outlook
2.2.3. Regional outlook
2.3. Competitive Insights

Chapter 3. Guillain-Barre Syndrome (GBS) Diagnostics Market Variables, Trends & Scope
3.1. Market Dynamics
3.1.1. Market driver analysis
3.1.2. Market restraint analysis
3.1.3. Market opportunities analysis
3.2. Guillain-Barre Syndrome (GBS) Diagnostics Market Analysis Tools
3.2.1. Industry Analysis - Porter’s
3.2.1.1. Supplier power
3.2.1.2. Buyer power
3.2.1.3. Substitution threat
3.2.1.4. Threat of new entrant
3.2.1.5. Competitive rivalry
3.2.2. PESTEL Analysis
3.2.2.1. Political landscape
3.2.2.2. Economic landscape
3.2.2.3. Social landscape
3.2.2.4. Technological landscape
3.2.2.5. Environmental landscape
3.2.2.6. Legal landscape
3.2.3. COVID-19 Impact Analysis
3.2.4. Case Studies

Chapter 4. Guillain-Barre Syndrome (GBS) Diagnostics Market: Test Estimates & Trend Analysis
4.1. Test Market Share, 2024 & 2030
4.2. Segment Dashboard
4.3. Global Guillain-Barre Syndrome (GBS) Diagnostics Market by Product Test Outlook
4.4. Lumbar Puncture
4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.5. Nerve Conduction Studies
4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.6. Electromyography
4.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.7. Others
4.7.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Guillain-Barre Syndrome (GBS) Diagnostics Market: End Use Estimates & Trend Analysis
5.1. End Use Market Share, 2024 & 2030
5.2. Segment Dashboard
5.3. Global Guillain-Barre Syndrome (GBS) Diagnostics Market by End Use Outlook
5.4. Hospitals and Clinics
5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.5. Diagnostic Laboratories
5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.6. Others
5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Guillain-Barre Syndrome (GBS) Diagnostics Market: Regional Estimates & Trend Analysis, By Product, By Test,By End Use
6.1. Regional Market Share Analysis, 2024 & 2030
6.2. Regional Market Dashboard
6.3. Global Regional Market Snapshot
6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
6.5. North America
6.5.1. U.S.
6.5.1.1. Key country dynamics
6.5.1.2. Regulatory framework/ reimbursement structure
6.5.1.3. Competitive scenario
6.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
6.5.2. Canada
6.5.2.1. Key country dynamics
6.5.2.2. Regulatory framework/ reimbursement structure
6.5.2.3. Competitive scenario
6.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
6.5.3. Mexico
6.5.3.1. Key country dynamics
6.5.3.2. Regulatory framework/ reimbursement structure
6.5.3.3. Competitive scenario
6.5.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Europe
6.6.1. UK
6.6.1.1. Key country dynamics
6.6.1.2. Regulatory framework/ reimbursement structure
6.6.1.3. Competitive scenario
6.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
6.6.2. Germany
6.6.2.1. Key country dynamics
6.6.2.2. Regulatory framework/ reimbursement structure
6.6.2.3. Competitive scenario
6.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
6.6.3. France
6.6.3.1. Key country dynamics
6.6.3.2. Regulatory framework/ reimbursement structure
6.6.3.3. Competitive scenario
6.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
6.6.4. Italy
6.6.4.1. Key country dynamics
6.6.4.2. Regulatory framework/ reimbursement structure
6.6.4.3. Competitive scenario
6.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
6.6.5. Spain
6.6.5.1. Key country dynamics
6.6.5.2. Regulatory framework/ reimbursement structure
6.6.5.3. Competitive scenario
6.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
6.6.6. Norway
6.6.6.1. Key country dynamics
6.6.6.2. Regulatory framework/ reimbursement structure
6.6.6.3. Competitive scenario
6.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
6.6.7. Sweden
6.6.7.1. Key country dynamics
6.6.7.2. Regulatory framework/ reimbursement structure
6.6.7.3. Competitive scenario
6.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
6.6.8. Denmark
6.6.8.1. Key country dynamics
6.6.8.2. Regulatory framework/ reimbursement structure
6.6.8.3. Competitive scenario
6.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
6.7. Asia Pacific
6.7.1. Japan
6.7.1.1. Key country dynamics
6.7.1.2. Regulatory framework/ reimbursement structure
6.7.1.3. Competitive scenario
6.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
6.7.2. China
6.7.2.1. Key country dynamics
6.7.2.2. Regulatory framework/ reimbursement structure
6.7.2.3. Competitive scenario
6.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
6.7.3. India
6.7.3.1. Key country dynamics
6.7.3.2. Regulatory framework/ reimbursement structure
6.7.3.3. Competitive scenario
6.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
6.7.4. Australia
6.7.4.1. Key country dynamics
6.7.4.2. Regulatory framework/ reimbursement structure
6.7.4.3. Competitive scenario
6.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
6.7.5. South Korea
6.7.5.1. Key country dynamics
6.7.5.2. Regulatory framework/ reimbursement structure
6.7.5.3. Competitive scenario
6.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
6.7.6. Thailand
6.7.6.1. Key country dynamics
6.7.6.2. Regulatory framework/ reimbursement structure
6.7.6.3. Competitive scenario
6.7.6.4. Singapore market estimates and forecasts 2018 to 2030 (USD Million)
6.8. Latin America
6.8.1. Brazil
6.8.1.1. Key country dynamics
6.8.1.2. Regulatory framework/ reimbursement structure
6.8.1.3. Competitive scenario
6.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
6.8.2. Argentina
6.8.2.1. Key country dynamics
6.8.2.2. Regulatory framework/ reimbursement structure
6.8.2.3. Competitive scenario
6.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
6.9. MEA
6.9.1. South Africa
6.9.1.1. Key country dynamics
6.9.1.2. Regulatory framework/ reimbursement structure
6.9.1.3. Competitive scenario
6.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
6.9.2. Saudi Arabia
6.9.2.1. Key country dynamics
6.9.2.2. Regulatory framework/ reimbursement structure
6.9.2.3. Competitive scenario
6.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
6.9.3. UAE
6.9.3.1. Key country dynamics
6.9.3.2. Regulatory framework/ reimbursement structure
6.9.3.3. Competitive scenario
6.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
6.9.4. Kuwait
6.9.4.1. Key country dynamics
6.9.4.2. Regulatory framework/ reimbursement structure
6.9.4.3. Competitive scenario
6.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.3. Key company market share/position analysis, 2024
7.4. Company Profiles
7.4.1. Cadwell Industries, Inc
7.4.1.1. Company overview
7.4.1.2. Financial performance
7.4.1.3. Technology test benchmarking
7.4.1.4. Strategic initiatives
7.4.2. Natus Medical Incorporated
7.4.2.1. Company overview
7.4.2.2. Financial performance
7.4.2.3. Technology test benchmarking
7.4.2.4. Strategic initiatives
7.4.3. Nihon Kohden Corporation
7.4.3.1. Company overview
7.4.3.2. Financial performance
7.4.3.3. Technology test benchmarking
7.4.3.4. Strategic initiatives
7.4.4. Medtronic plc
7.4.4.1. Company overview
7.4.4.2. Financial performance
7.4.4.3. Technology test benchmarking
7.4.4.4. Strategic initiatives
7.4.5. Bionen Medical Devices
7.4.5.1. Company overview
7.4.5.2. Financial performance
7.4.5.3. Technology test benchmarking
7.4.5.4. Strategic initiatives
7.4.6. Deymed Diagnostic
7.4.6.1. Company overview
7.4.6.2. Financial performance
7.4.6.3. Technology test benchmarking
7.4.6.4. Strategic initiatives
7.4.7. Neurosoft
7.4.7.1. Company overview
7.4.7.2. Financial performance
7.4.7.3. Technology test benchmarking
7.4.7.4. Strategic initiatives
7.4.8. Alpine Biomed
7.4.8.1. Company overview
7.4.8.2. Financial performance
7.4.8.3. Technology test benchmarking
7.4.8.4. Strategic initiatives
7.4.9. EMS Biomedical
7.4.9.1. Company overview
7.4.9.2. Financial performance
7.4.9.3. Technology test benchmarking
7.4.9.4. Strategic initiatives
7.4.10. Rochester Electro-Medical, Inc
7.4.10.1. Company overview
7.4.10.2. Financial performance
7.4.10.3. Technology test benchmarking
7.4.10.4. Strategic initiatives

List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 North America Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by test, 2018 - 2030 (USD Million)
Table 4 North America Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 5 U.S. Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by test, 2018 - 2030 (USD Million)
Table 6 U.S. Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 7 Canada Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by test, 2018 - 2030 (USD Million)
Table 8 Canada Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 9 Mexico Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by test, 2018 - 2030 (USD Million)
Table 10 Mexico Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 11 Europe Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by test, 2018 - 2030 (USD Million)
Table 12 Europe Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 13 UK Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by test, 2018 - 2030 (USD Million)
Table 14 UK Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 15 Germany Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by test, 2018 - 2030 (USD Million)
Table 16 Germany Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 17 France Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by test, 2018 - 2030 (USD Million)
Table 18 France Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 19 Italy Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by test, 2018 - 2030 (USD Million)
Table 20 Italy Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 21 Spain Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by test, 2018 - 2030 (USD Million)
Table 22 Spain Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 23 Denmark Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by test, 2018 - 2030 (USD Million)
Table 24 Denmark Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 25 Sweden Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by test, 2018 - 2030 (USD Million)
Table 26 Sweden Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 27 Norway Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by test, 2018 - 2030 (USD Million)
Table 28 Norway Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 29 Asia Pacific Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by test, 2018 - 2030 (USD Million)
Table 30 Asia Pacific Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 31 Japan Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by test, 2018 - 2030 (USD Million)
Table 32 Japan Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 33 China Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by test, 2018 - 2030 (USD Million)
Table 34 China Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 35 India Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by test, 2018 - 2030 (USD Million)
Table 36 India Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 37 Australia Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by test, 2018 - 2030 (USD Million)
Table 38 Australia Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 39 South Korea Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by test, 2018 - 2030 (USD Million)
Table 40 South Korea Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 41 Thailand Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by test, 2018 - 2030 (USD Million)
Table 42 Thailand Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 43 Latin America Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by test, 2018 - 2030 (USD Million)
Table 44 Latin America Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 45 Brazil Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by test, 2018 - 2030 (USD Million)
Table 46 Brazil Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 47 Argentina Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by test, 2018 - 2030 (USD Million)
Table 48 Argentina Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 49 MEA Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by test, 2018 - 2030 (USD Million)
Table 50 MEA Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 51 South Africa Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by test, 2018 - 2030 (USD Million)
Table 52 South Africa Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 53 Saudi Arabia Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by test, 2018 - 2030 (USD Million)
Table 54 Saudi Arabia Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 55 UAE Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by test, 2018 - 2030 (USD Million)
Table 56 UAE Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 57 Kuwait Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by test, 2018 - 2030 (USD Million)
Table 58 Kuwait Guillain-Barre syndrome (GBS) diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)

List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Guillain-Barre Syndrome (GBS) Diagnostics market outlook
Fig. 9 Guillain-Barre Syndrome (GBS) Diagnostics competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Guillain-Barre Syndrome (GBS) Diagnostics market driver impact
Fig. 15 Guillain-Barre Syndrome (GBS) Diagnostics market restraint impact
Fig. 16 Guillain-Barre Syndrome (GBS) Diagnostics market strategic initiatives analysis
Fig. 17 Guillain-Barre Syndrome (GBS) Diagnostics market: Test analysis
Fig. 18 Guillain-Barre Syndrome (GBS) Diagnostics market: Test outlook and key takeaways
Fig. 19 Clinical writing market estimates and forecast, 2018 - 2030
Fig. 20 Lumbar puncture market estimates and forecast, 2018 - 2030
Fig. 21 Nerve conduction studies market estimates and forecast, 2018 - 2030
Fig. 22 Electromyography market estimates and forecast, 2018 - 2030
Fig. 23 Others market estimates and forecast, 2018 - 2030
Fig. 24 Guillain-Barre Syndrome (GBS) Diagnostics market: End use movement analysis
Fig. 25 Guillain-Barre Syndrome (GBS) Diagnostics market: End use outlook and key takeaways
Fig. 26 Hospitals and clinics market estimates and forecast, 2018 - 2030
Fig. 27 Diagnostic laboratories market estimates and forecast, 2018 - 2030
Fig. 28 Global Guillain-Barre Syndrome (GBS) Diagnostics market: Regional movement analysis
Fig. 29 Global Guillain-Barre Syndrome (GBS) Diagnostics market: Regional outlook and key takeaways
Fig. 30 Global Guillain-Barre Syndrome (GBS) Diagnostics market share and leading players
Fig. 31 North America market share and leading players
Fig. 32 Europe market share and leading players
Fig. 33 Asia Pacific market share and leading players
Fig. 34 Latin America market share and leading players
Fig. 35 Middle East & Africa market share and leading players
Fig. 36 North America: SWOT
Fig. 37 Europe SWOT
Fig. 38 Asia Pacific SWOT
Fig. 39 Latin America SWOT
Fig. 40 MEA SWOT
Fig. 41 North America market estimates and forecasts, 2018 - 2030
Fig. 42 U.S. market estimates and forecasts, 2018 - 2030
Fig. 43 Canada market estimates and forecasts, 2018 - 2030
Fig. 44 Mexico market estimates and forecasts, 2018 - 2030
Fig. 45 Europe market estimates and forecasts, 2018 - 2030
Fig. 46 UK market estimates and forecasts, 2018 - 2030
Fig. 47 Germany market estimates and forecasts, 2018 - 2030
Fig. 48 France market estimates and forecasts, 2018 - 2030
Fig. 49 Italy market estimates and forecasts, 2018 - 2030
Fig. 50 Spain market estimates and forecasts, 2018 - 2030
Fig. 51 Denmark market estimates and forecasts, 2018 - 2030
Fig. 52 Sweden market estimates and forecasts, 2018 - 2030
Fig. 53 Norway market estimates and forecasts, 2018 - 2030
Fig. 54 Asia Pacific market estimates and forecasts, 2018 - 2030
Fig. 55 China market estimates and forecasts, 2018 - 2030
Fig. 56 Japan market estimates and forecasts, 2018 - 2030
Fig. 57 India market estimates and forecasts, 2018 - 2030
Fig. 58 Thailand market estimates and forecasts, 2018 - 2030
Fig. 59 South Korea market estimates and forecasts, 2018 - 2030
Fig. 60 Australia market estimates and forecasts, 2018 - 2030
Fig. 61 Latin America market estimates and forecasts, 2018 - 2030
Fig. 62 Brazil market estimates and forecasts, 2018 - 2030
Fig. 63 Argentina market estimates and forecasts, 2018 - 2030
Fig. 64 Middle East and Africa market estimates and forecasts, 2018 - 2030
Fig. 65 South Africa market estimates and forecasts, 2018 - 2030
Fig. 66 Saudi Arabia market estimates and forecasts, 2018 - 2030
Fig. 67 UAE market estimates and forecasts, 2018 - 2030
Fig. 68 Kuwait market estimates and forecasts, 2018 - 2030
Fig. 69 Market share of key market players- Guillain-Barre Syndrome (GBS) Diagnostics market
Fig. 70 Key Company Categorization
Fig. 71 Company Market Share/Position Analysis, 2024
Fig. 72 Strategic Framework